Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4293)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2024 (publication date) through Feb 4, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Cui JY, Ma J, Gao XX, Sheng ZM, Pan ZX, Shi LH, Zhang BG. Unraveling the role of cancer-associated fibroblasts in colorectal cancer. World J Gastrointest Oncol 2024; 16(12): 4565-4578 [PMID: 39678792 DOI: 10.4251/wjgo.v16.i12.4565] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Cui JY, Ma J, Gao XX, Sheng ZM, Pan ZX, Shi LH, Zhang BG. Unraveling the role of cancer-associated fibroblasts in colorectal cancer. World J Gastrointest Oncol 2024; 16(12): 4565-4578 [PMID: 39678792 DOI: 10.4251/wjgo.v16.i12.4565] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i12/4565.htm |
| Number | Citing Articles |
| 1 |
Mathieu Reslinger, Michelina Plateroti. Stromal cells in normal colon and colon cancers: importance of thyroid hormone signaling. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-08005-0
|
| 2 |
Chengyong Qian, Lingling Ren, Shuyuan Zhu, Fangling Chen, Haiping Shen, Xiangcheng Hu, Guanglan Chen. Current perspectives and trends in colorectal cancer and cancer-associated fibroblasts: a review and bibliometric analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1618742
|
| 3 |
Abdelrahman Homedan, Darpan N. Pandya, Nicholas J. Schnicker, Thaddeus J. Wadas. Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress. EJNMMI Radiopharmacy and Chemistry 2025; 10(1) doi: 10.1186/s41181-025-00356-5
|
| 4 |
Paola Chiodelli, Andrea Papait, Lorenzo Agoni, Federico Quaglia, Antonietta Rosa Silini, Ornella Parolini. The tumor ecosystem: Rewiring an open, systemically integrated network for therapeutic gain. Biomedicine & Pharmacotherapy 2026; 195: 119047 doi: 10.1016/j.biopha.2026.119047
|
| 5 |
Sounik Manna, Angsuman Das Chaudhuri, Malay Dolai, Subhasis Das, Sujata Maiti Choudhury. Baicalein modulates colorectal tumor microenvironment to suppress growth, metastasis, and immune escape. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11239-y
|
| 6 |
Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi, Priya Priyadarshini Nayak, J. Bethanney Janney, Gurjant Singh, Aashna Sinha, Nodira Rabbimova, Hayder Naji Sameer, Ahmed Yaseen, Rasim M. Salih, Mohaned Adil. Exosomal CeRNAs from the tumor microenvironment: hidden drivers of colorectal cancer progression. Journal of Molecular Histology 2026; 57(1) doi: 10.1007/s10735-026-10724-3
|
| 7 |
Maelle Picard, Arnaud Guille, Pascal Finetti, Bernadette De Rauglaudre, Nadiya Belfil, Lenaïg Mescam, David Jeremie Birnbaum, François Bertucci, Emilie Mamessier. Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. Journal for ImmunoTherapy of Cancer 2026; 14(2): e013356 doi: 10.1136/jitc-2025-013356
|
| 8 |
Ugne Silinskaite, Jurate Valciukiene, Matas Jakubauskas, Tomas Poskus. The Immune Environment in Colorectal Adenoma: A Systematic Review. Biomedicines 2025; 13(3): 699 doi: 10.3390/biomedicines13030699
|
| 9 |
Mrunali Jayaprakash, Deekshit Vijaya Kumar, Gunimala Chakraborty, Anirban Chakraborty, Vinod Kumar. Bacteria-mediated cancer therapy (BMCT): Therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer. Biomedicine & Pharmacotherapy 2025; 192: 118559 doi: 10.1016/j.biopha.2025.118559
|
| 10 |
Tianwei Chen, Yebin Yang, Jing Shi, Fanhe Dong, Lesi Xie, Yuqiang Shan, Xiang Wang. Multi-omics factor analysis identifies the Tensin 1-Fermitin family homologue 2–Fibronectin 1–Integrin signaling axis as a prognostic determinant in colorectal cancer. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00386-0
|